Actively Recruiting
AVEIR DR Coverage With Evidence Development (CED) Study
Led by Abbott Medical Devices · Updated on 2025-04-06
2812
Participants Needed
1
Research Sites
339 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the dual chamber Aveir Leadless Pacemaker device (aka Aveir™ DR LP system).
CONDITIONS
Official Title
AVEIR DR Coverage With Evidence Development (CED) Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Medicare beneficiaries implanted with an Aveir DR leadless pacemaker on or after the study start date (date of Aveir DR market approval)
- Medicare beneficiaries implanted with a full system dual-chamber transvenous pacemaker on or after the study start date
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Abbott
Sylmar, California, United States, 91342
Actively Recruiting
Research Team
N
Nicole Harbert
CONTACT
S
Stephanie Delgado
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here